Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting

被引：0
|
作者：
Gimenez, Estela [1 ]
Solano, Carlos [2 ,3 ]
Bravo, Dayana [1 ]
Amat, Paula [2 ]
Jose Remigia, Maria [2 ]
Alberola, Juan [4 ]
Navarro, David [1 ,4 ]
机构：
[1] Hosp Clin Univ, Microbiol Serv, Inst Res INCLIVA, Valencia, Spain
[2] Hosp Clin Univ, Hematol & Med Oncol Serv, Inst Res INCLIVA, Valencia, Spain
[3] Univ Valencia, Dept Med, Sch Med, Valencia, Spain
[4] Univ Valencia, Dept Microbiol, Sch Med, Valencia, Spain
来源：
CLINICAL TRANSPLANTATION | 2014年 / 28卷 / 04期
关键词：
PCR KIT; PLASMA; ASSAY; QUANTITATION; THERAPY; SCT;
D O I：
10.1111/ctr.12332
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [31] Monitoring Epstein-Barr virus in adults following allogeneic haematopoietic stem cell transplantation
    Buchholz, S
    Dammann, E
    Flik, J
    Dobbelstein, C
    Stadler, M
    Kamal, H
    Krauter, J
    Eder, M
    Hertenstein, B
    Schulz, T
    Ganser, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S169 - S170
  • [32] CONGENITAL INFECTION WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS
    JONCAS, JH
    WILLS, A
    MCLAUGHLIN, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1977, 117 (12) : 1417 - 1418
  • [33] Incidence, risk factors, and clinical outcomes associated with Epstein-Barr virus-DNAemia and Epstein-Barr virus-associated disease in patients after haploidentical allogeneic stem cell transplantation: A single-center study
    Zhou, Ling
    Gao, Zhi-Yong
    Lu, Dao-Pei
    CLINICAL TRANSPLANTATION, 2020, 34 (06)
  • [34] Management of Epstein-Barr virus infection after haematopoietic stem cell transplantation in 80 paediatric allogeneic recipients
    Faraci, M.
    Caviglia, I.
    Morreale, G.
    Lanino, E.
    Cuzzubbo, D.
    Giardino, S.
    Di Marco, E.
    Cirillo, C.
    Scuderi, F.
    Dini, G.
    Terranova, P.
    Castagnola, E.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S221 - S221
  • [35] Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
    Coppoletta, Stefania
    Tedone, Elisabetta
    Galano, Barbara
    Soracco, Monica
    Raiola, Anna Maria
    Lamparelli, Teresa
    Gualandi, Francesca
    Bregante, Stefania
    Ibatici, Adalberto
    di Grazia, Carmen
    Dominietto, Alida
    Varaldo, Riccardo
    Bruno, Barbara
    Frassoni, Francesco
    Van Lint, Maria Teresa
    Bacigalupo, Andrea
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 901 - 907
  • [36] Allogeneic non-myeloablative stem cell transplantation for chronic active Epstein Barr virus infection (CAEBV).
    Uehara, T
    Nakaseko, C
    Hara, S
    Harima, A
    Yokota, T
    Nishimura, M
    BLOOD, 2002, 100 (11) : 461B - 461B
  • [37] Increased Epstein-Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation
    Kong, Xin
    Xu, Ziyi
    Wu, Yanjun
    Tang, Xiaowen
    Xue, Shengli
    Miao, Miao
    Han, Yue
    Wang, Ying
    Chen, Suning
    Sun, Aining
    Qiu, Huiying
    Wu, Depei
    Zhao, Ye
    Chen, Feng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [38] Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation
    Okamura, T
    Hatsukawa, Y
    Arai, H
    Inoue, M
    Kawa, K
    LANCET, 2000, 356 (9225): : 223 - 224
  • [39] Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation
    Volfova, P.
    Lengerova, M.
    Winterova, J.
    Racil, Z.
    Dvorakova, D.
    Mayer, J.
    INFECTION, 2012, 40 (05) : 583 - 587
  • [40] Successful Cord Blood Stem Cell Transplantation for an Adult Case of Chronic Active Epstein-Barr Virus Infection
    Saburi, Masuho
    Ogata, Masao
    Satou, Takako
    Yoshida, Natsumi
    Nagamatsu, Kentaro
    Nashimoto, Yuko
    Moroga, Yui
    Takano, Kuniko
    Kohno, Kazuhiro
    Shirao, Kuniaki
    INTERNAL MEDICINE, 2016, 55 (23) : 3499 - 3504
12345